Latest News

Use of tPA for ischemic stroke nearly doubled from 2003 to 2011

Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. A research team reports both an overall increase in the use of tPA to dissolve clots blocking arteries supplying the brain and administration of the potentially life-saving drug to a more diverse group of patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Trust your aha! moments: Experiments show they're probably right

  • Scientists use synthetic gene and magnets to alter behavior of mice, fish

  • Teen girls see big drop in chemical exposure with switch in cosmetics

  • Female traders can reduce market crashes, expert says

  • Toxic byproduct of hemoglobin could provide clues for cerebral hemorrhage and Creutzfeldt-Jakob Disease

  • Clinician communication reduced distress related to the detection of incidental nodules

  • Talk about yourself on social media?

  • New mothers with postpartum psychiatric disorders face increased risk of suicide, study shows

  • Combining two techniques to 'rewire' the brain may improve arm, hand movement for stroke survivors

  • Scientists map roots of premeditated, violent 'intent' in animal brain

  •